Unio Capital LLC Abb Vie Inc. Transaction History

Unio Capital LLC

$240 Million
Q3 2024

A detailed history of Unio Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Unio Capital LLC holds 1,300 shares of ABBV stock, worth $234,000. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,300

Previous 1,630 20.25%

Holding current value

$234,000

Previous $279,000 8.24%

% of portfolio

0.11%

Previous 0.12%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $54,067 - $65,778	-330 Reduced 20.25%	1,300 $256,000
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $61,916 - $72,304	-400 Reduced 19.7%	1,630 $279,000
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $23,973 - $27,315	-150 Reduced 6.88%	2,030 $369,000
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $2,064 - $2,324	15 Added 0.69%	2,180 $337,000
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $39,753 - $49,470	-300 Reduced 12.17%	2,165 $291,000
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $180,762 - $208,175	-1,250 Reduced 33.65%	2,465 $392,000
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $39,221 - $49,863	-285 Reduced 7.12%	3,715 $569,000
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $106 - $120	-1 Reduced 0.02%	4,000 $431,000
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $304,477 - $339,205	-2,894 Reduced 41.97%	4,001 $451,000
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $73,245 - $98,889	-910 Reduced 11.66%	6,895 $739,000
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $4,553 - $5,343	53 Added 0.68%	7,805 $658,000
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $242,004 - $366,908	3,752 Added 93.8%	7,752 $591,000
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $14,426 - $18,050	-200 Reduced 4.76%	4,000 $354,000
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $15,745 - $18,930	-250 Reduced 5.62%	4,200 $318,000
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $318,645 - $407,303	-4,850 Reduced 52.15%	4,450 $325,000
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $38,925 - $48,005	-500 Reduced 5.1%	9,300 $857,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $106,692 - $118,608	-1,200 Reduced 10.91%	9,800 $927,000
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $17,956 - $21,246	-200 Reduced 1.79%	11,000 $1.02 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $27,603 - $36,963	300 Added 2.75%	11,200 $1.06 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $976,204 - $1.07 Million	10,900	10,900 $1.05 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Unio Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Unio Capital LLC with notifications on news.

Account